Cannabidiol for Viral Diseases: Hype or Hope?

Pharmacogenomics: Hope or Hype?

Much has been made of the potential for personalnot altruistic companies. Incyte Inc. alone holds US ised medicine, where a genomic screen of a patient patents on more than 350 genes and has an estimated could determine which drugs will work and be free of 6,500 applications pending with 10 more applied for side effects in an individual. Much of the hope based each week [3]. They hope to make p...

The relationship between periodontitis and systemic diseases - hype or hope?

Investigations have definitely acknowledged a clinically relevant two-way relationship between periodontitis and certain systemic diseases and conditions, which are significant for the dentist in the daily practice and for a physician as well. This review article yields the most up-to-date information on the role of periodontal diseases in systemic diseases, that include cardiovascular diseases...

Mesenchymal stem cells in autoimmune diseases: hype or hope?

Intervention with mesenchymal stem cells (MSCs) represents a promising therapeutic tool in treatment-refractory autoimmune diseases. A new report by Schurgers and colleagues in a previous issue of Arthritis Research & Therapy sheds novel mechanistic insight into the pathways employed by MSCs to suppress T-cell proliferation in vitro, but, at the same time, indicates that MSCs do not influence T...

Microarrays for Bacterial Pathogens — Hope or Hype?

Despite advances in the treatment of infectious disease, pathogenic bacteria still represent one of the most important threats to human health worldwide. Many infectious disease agents have never been controlled, or have re-emerged as global pathogens, while others pose a new threat. Media and scientific attention has focused on a range of problems, including the alarming spread of antibiotic r...

Genital herpes: hype or hope?